✦ LIBER ✦

Donepezil is an `effective and realistic symptomatic treatment' long-term in patients with mild-to-moderate Alzheimer's Disease (AD),

Book ID: 120868959
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 151 KB
Volume: 1248
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012480-00038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and tolerability of don

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

✍ Pierre Tariot, Steven Salloway, Jane Yardley, Joan Mackell, Margaret Moline 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 197 KB

Updated cost-effectiveness projections f

Updated cost-effectiveness projections for donepezil in the treatment of patients with mild-to-moderately severe Alzheimer's disease in the UK

✍ Maclaine, Grant; Getsios, Denis; Blume, Steve; Ishak, Jack 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Long-term safety and tolerability of don

Long-term safety and tolerability of donepezil 23 mg in patients with moderate-to-severe Alzheimer's disease: An 18-month analysis

✍ Farlow, Martin; Richardson, Sharon; Mackell, Joan; Sun, Yijun 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Long-term efficacy and safety of galanta

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial

✍ T. Pirttilä; G. Wilcock; L. Truyen; C. V. Damaraju 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Safety and effectiveness of long-term bu

Safety and effectiveness of long-term budesonide treatment in maintaining remission in patients with mild-to-moderate Crohn's disease

✍ Antonio Tursi; Gian Marco Giorgetti; Giovanni Brandimarte; Walter Elisei 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

A multinational, randomised, 12-week stu

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

✍ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati